ID   FSCN1_HUMAN             Reviewed;         493 AA.
AC   Q16658; A6NI89; B2RE97; Q96IC5; Q96IH1; Q9BRF1;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   28-JUN-2023, entry version 222.
DE   RecName: Full=Fascin;
DE   AltName: Full=55 kDa actin-bundling protein;
DE   AltName: Full=Singed-like protein;
DE   AltName: Full=p55;
GN   Name=FSCN1; Synonyms=FAN1, HSN, SNL;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Teratocarcinoma;
RX   PubMed=8068206; DOI=10.1089/dna.1994.13.821;
RA   Duh F.-M., Latif F., Weng Y., Geil L., Modi W., Stackhouse T.,
RA   Matsumura F., Duan D.R., Linehan W.M., Lerman M.I., Gnarra J.R.;
RT   "cDNA cloning and expression of the human homolog of the sea urchin fascin
RT   and Drosophila singed genes which encodes an actin-bundling protein.";
RL   DNA Cell Biol. 13:821-827(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7933116; DOI=10.1128/jvi.68.11.7320-7328.1994;
RA   Mosialos G., Yamashiro S., Baughman R.W., Matsudaira P., Vara L.,
RA   Matsumura F., Kieff E., Birkenbach M.;
RT   "Epstein-Barr virus infection induces expression in B lymphocytes of a
RT   novel gene encoding an evolutionarily conserved 55-kilodalton actin-
RT   bundling protein.";
RL   J. Virol. 68:7320-7328(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Bros M., Ross X.L., Reske-Kunz A.B., Ross R.;
RT   "Human fascin gene sequence.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Eye, Lung, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-32; 44-63; 69-82; 111-149; 159-185; 202-217; 230-241;
RP   248-271; 314-341; 409-426 AND 469-493, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT THR-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 119-149; 202-217; 230-241; 314-330 AND 380-389, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=3525578; DOI=10.1083/jcb.103.2.631;
RA   Yamashiro-Matsumura S., Matsumura F.;
RT   "Intracellular localization of the 55-kD actin-bundling protein in cultured
RT   cells: spatial relationships with actin, alpha-actinin, tropomyosin, and
RT   fimbrin.";
RL   J. Cell Biol. 103:631-640(1986).
RN   [12]
RP   PHOSPHORYLATION.
RX   PubMed=8647875; DOI=10.1074/jbc.271.21.12632;
RA   Yamakita Y., Ono S., Matsumura F., Yamashiro S.;
RT   "Phosphorylation of human fascin inhibits its actin binding and bundling
RT   activities.";
RL   J. Biol. Chem. 271:12632-12638(1996).
RN   [13]
RP   FUNCTION.
RX   PubMed=9362073; DOI=10.1091/mbc.8.11.2345;
RA   Adams J.C.;
RT   "Characterization of cell-matrix adhesion requirements for the formation of
RT   fascin microspikes.";
RL   Mol. Biol. Cell 8:2345-2363(1997).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=9571235; DOI=10.1091/mbc.9.5.993;
RA   Yamashiro S., Yamakita Y., Ono S., Matsumura F.;
RT   "Fascin, an actin-bundling protein, induces membrane protrusions and
RT   increases cell motility of epithelial cells.";
RL   Mol. Biol. Cell 9:993-1006(1998).
RN   [15]
RP   PHOSPHORYLATION AT SER-39, AND MUTAGENESIS OF SER-39.
RX   PubMed=8999969; DOI=10.1074/jbc.272.4.2527;
RA   Ono S., Yamakita Y., Yamashiro S., Matsudaira P.T., Gnarra J.R.,
RA   Obinata T., Matsumura F.;
RT   "Identification of an actin binding region and a protein kinase C
RT   phosphorylation site on human fascin.";
RL   J. Biol. Chem. 272:2527-2533(1997).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-38, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20137952; DOI=10.1016/j.cub.2009.12.035;
RA   Li A., Dawson J.C., Forero-Vargas M., Spence H.J., Yu X., Konig I.,
RA   Anderson K., Machesky L.M.;
RT   "The actin-bundling protein fascin stabilizes actin in invadopodia and
RT   potentiates protrusive invasion.";
RL   Curr. Biol. 20:339-345(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   FUNCTION, MUTAGENESIS OF 36-SER--SER-39, AND PHOSPHORYLATION.
RX   PubMed=22155786; DOI=10.1126/scisignal.2002060;
RA   Deinhardt K., Kim T., Spellman D.S., Mains R.E., Eipper B.A., Neubert T.A.,
RA   Chao M.V., Hempstead B.L.;
RT   "Neuronal growth cone retraction relies on proneurotrophin receptor
RT   signaling through Rac.";
RL   Sci. Signal. 4:RA82-RA82(2011).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [22]
RP   INTERACTION WITH PLXNB3, AND SUBCELLULAR LOCATION.
RX   PubMed=21706053; DOI=10.1038/onc.2011.256;
RA   Li X., Law J.W., Lee A.Y.;
RT   "Semaphorin 5A and plexin-B3 regulate human glioma cell motility and
RT   morphology through Rac1 and the actin cytoskeleton.";
RL   Oncogene 31:595-610(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127; SER-234 AND THR-239, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-399, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS), AND DOMAIN.
RX   PubMed=20434460; DOI=10.1016/j.jmb.2010.04.043;
RA   Sedeh R.S., Fedorov A.A., Fedorov E.V., Ono S., Matsumura F., Almo S.C.,
RA   Bathe M.;
RT   "Structure, evolutionary conservation, and conformational dynamics of Homo
RT   sapiens fascin-1, an F-actin crosslinking protein.";
RL   J. Mol. Biol. 400:589-604(2010).
RN   [27] {ECO:0007744|PDB:3LLP}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS), FUNCTION, DOMAIN, AND MUTAGENESIS
RP   OF HIS-392; LYS-471 AND ALA-488.
RX   PubMed=20393565; DOI=10.1038/nature08978;
RA   Chen L., Yang S., Jakoncic J., Zhang J.J., Huang X.Y.;
RT   "Migrastatin analogues target fascin to block tumour metastasis.";
RL   Nature 464:1062-1066(2010).
RN   [28]
RP   ERRATUM OF PUBMED:20393565, AND RETRACTION NOTICE OF PUBMED:20393565 OF TWO
RP   3D-STRUCTURES.
RX   DOI=10.1038/nature10281;
RA   Chen L., Yang S., Jakoncic J., Zhang J.J., Huang X.Y.;
RL   Nature 476:0-0(2011).
RN   [29] {ECO:0007744|PDB:3P53}
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS), FUNCTION, DOMAIN, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF LYS-22; LYS-43; ARG-100; ARG-109;
RP   150-LYS-LYS-151; LYS-247; ARG-271; LYS-313; ARG-341; ARG-348; LYS-353;
RP   LYS-358; ARG-398 AND LYS-464.
RX   PubMed=21685497; DOI=10.1074/jbc.m111.251439;
RA   Jansen S., Collins A., Yang C., Rebowski G., Svitkina T., Dominguez R.;
RT   "Mechanism of actin filament bundling by fascin.";
RL   J. Biol. Chem. 286:30087-30096(2011).
RN   [30] {ECO:0007744|PDB:4GOV, ECO:0007744|PDB:4GOY, ECO:0007744|PDB:4GP0, ECO:0007744|PDB:4GP3}
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS), FUNCTION, AND MUTAGENESIS OF
RP   PHE-29; SER-39; 149-ARG--ARG-151; 247-LYS--LYS-250 AND LYS-358.
RX   PubMed=23184945; DOI=10.1074/jbc.m112.427971;
RA   Yang S., Huang F.K., Huang J., Chen S., Jakoncic J., Leo-Macias A.,
RA   Diaz-Avalos R., Chen L., Zhang J.J., Huang X.Y.;
RT   "Molecular mechanism of fascin function in filopodial formation.";
RL   J. Biol. Chem. 288:274-284(2013).
CC   -!- FUNCTION: Actin-binding protein that contains 2 major actin binding
CC       sites (PubMed:21685497, PubMed:23184945). Organizes filamentous actin
CC       into parallel bundles (PubMed:20393565, PubMed:21685497,
CC       PubMed:23184945). Plays a role in the organization of actin filament
CC       bundles and the formation of microspikes, membrane ruffles, and stress
CC       fibers (PubMed:22155786). Important for the formation of a diverse set
CC       of cell protrusions, such as filopodia, and for cell motility and
CC       migration (PubMed:20393565, PubMed:21685497, PubMed:23184945). Mediates
CC       reorganization of the actin cytoskeleton and axon growth cone collapse
CC       in response to NGF (PubMed:22155786). {ECO:0000269|PubMed:20137952,
CC       ECO:0000269|PubMed:20393565, ECO:0000269|PubMed:21685497,
CC       ECO:0000269|PubMed:22155786, ECO:0000269|PubMed:23184945,
CC       ECO:0000269|PubMed:9362073, ECO:0000269|PubMed:9571235}.
CC   -!- SUBUNIT: Interacts with RUFY3 (via N-terminus); the interaction induces
CC       neuron axon development (By similarity). Interacts with NGFR (By
CC       similarity). Associates with CTNNB1 (By similarity). Interacts with
CC       PLXNB3 (PubMed:21706053). {ECO:0000250|UniProtKB:P85845,
CC       ECO:0000250|UniProtKB:Q61553, ECO:0000269|PubMed:21706053}.
CC   -!- INTERACTION:
CC       Q16658; Q9BXW9: FANCD2; NbExp=6; IntAct=EBI-351076, EBI-359343;
CC       Q16658; P40692: MLH1; NbExp=7; IntAct=EBI-351076, EBI-744248;
CC       Q16658; Q9ULL4: PLXNB3; NbExp=2; IntAct=EBI-351076, EBI-311073;
CC       Q16658; P63104: YWHAZ; NbExp=3; IntAct=EBI-351076, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:21706053,
CC       ECO:0000269|PubMed:9571235}. Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:21685497}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:21685497, ECO:0000269|PubMed:3525578,
CC       ECO:0000269|PubMed:9571235}. Cytoplasm, cytoskeleton, stress fiber
CC       {ECO:0000269|PubMed:21706053}. Cell projection, filopodium
CC       {ECO:0000269|PubMed:20137952, ECO:0000269|PubMed:21685497,
CC       ECO:0000269|PubMed:3525578}. Cell projection, invadopodium
CC       {ECO:0000269|PubMed:20137952}. Cell projection, microvillus
CC       {ECO:0000269|PubMed:9571235}. Cell junction
CC       {ECO:0000269|PubMed:9571235}. Note=Colocalized with RUFY3 and F-actin
CC       at filipodia of the axonal growth cone. Colocalized with DBN1 and F-
CC       actin at the transitional domain of the axonal growth cone (By
CC       similarity). {ECO:0000250|UniProtKB:Q61553,
CC       ECO:0000269|PubMed:21706053}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DOMAIN: Composed of four fascin beta-trefoil domains.
CC       {ECO:0000269|PubMed:20393565, ECO:0000269|PubMed:20434460,
CC       ECO:0000269|PubMed:21685497, ECO:0000269|PubMed:23184945}.
CC   -!- PTM: Phosphorylation at Ser-39 inhibits actin-binding (PubMed:8647875,
CC       PubMed:8999969). Phosphorylation is required for the reorganization of
CC       the actin cytoskeleton in response to NGF (PubMed:22155786).
CC       {ECO:0000269|PubMed:22155786, ECO:0000269|PubMed:8647875,
CC       ECO:0000269|PubMed:8999969}.
CC   -!- SIMILARITY: Belongs to the fascin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH07539.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/44342/FSCN1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U03057; AAA86442.1; -; mRNA.
DR   EMBL; U09873; AAA62201.1; -; mRNA.
DR   EMBL; AY044229; AAL01526.1; -; Genomic_DNA.
DR   EMBL; AK316607; BAG38194.1; -; mRNA.
DR   EMBL; BT006636; AAP35282.1; -; mRNA.
DR   EMBL; AC006483; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471144; EAW87346.1; -; Genomic_DNA.
DR   EMBL; BC000521; AAH00521.1; -; mRNA.
DR   EMBL; BC006304; AAH06304.1; -; mRNA.
DR   EMBL; BC007539; AAH07539.1; ALT_INIT; mRNA.
DR   EMBL; BC007643; AAH07643.1; -; mRNA.
DR   EMBL; BC007948; AAH07948.1; -; mRNA.
DR   EMBL; BC007988; AAH07988.1; -; mRNA.
DR   CCDS; CCDS5342.1; -.
DR   PIR; I38621; I38621.
DR   RefSeq; NP_003079.1; NM_003088.3.
DR   PDB; 1DFC; X-ray; 2.90 A; A/B=1-493.
DR   PDB; 3LLP; X-ray; 1.80 A; A/B=1-493.
DR   PDB; 3P53; X-ray; 2.00 A; A/B=1-493.
DR   PDB; 4GOV; X-ray; 2.20 A; A/B=1-493.
DR   PDB; 4GOY; X-ray; 2.30 A; A/B=1-493.
DR   PDB; 4GP0; X-ray; 2.50 A; A/B=1-493.
DR   PDB; 4GP3; X-ray; 2.25 A; A/B=1-493.
DR   PDB; 6B0T; X-ray; 2.80 A; A/B/C/D/E/F=7-493.
DR   PDB; 6I0Z; X-ray; 1.77 A; A/B=1-493.
DR   PDB; 6I10; X-ray; 2.10 A; A=1-493.
DR   PDB; 6I11; X-ray; 1.67 A; A=1-493.
DR   PDB; 6I12; X-ray; 1.65 A; A=1-493.
DR   PDB; 6I13; X-ray; 1.79 A; A=1-493.
DR   PDB; 6I14; X-ray; 1.73 A; A=1-493.
DR   PDB; 6I15; X-ray; 1.91 A; A=1-493.
DR   PDB; 6I16; X-ray; 2.00 A; A=1-493.
DR   PDB; 6I17; X-ray; 1.56 A; A=1-493.
DR   PDB; 6I18; X-ray; 1.49 A; A=1-493.
DR   PDBsum; 1DFC; -.
DR   PDBsum; 3LLP; -.
DR   PDBsum; 3P53; -.
DR   PDBsum; 4GOV; -.
DR   PDBsum; 4GOY; -.
DR   PDBsum; 4GP0; -.
DR   PDBsum; 4GP3; -.
DR   PDBsum; 6B0T; -.
DR   PDBsum; 6I0Z; -.
DR   PDBsum; 6I10; -.
DR   PDBsum; 6I11; -.
DR   PDBsum; 6I12; -.
DR   PDBsum; 6I13; -.
DR   PDBsum; 6I14; -.
DR   PDBsum; 6I15; -.
DR   PDBsum; 6I16; -.
DR   PDBsum; 6I17; -.
DR   PDBsum; 6I18; -.
DR   AlphaFoldDB; Q16658; -.
DR   SMR; Q16658; -.
DR   BioGRID; 112508; 281.
DR   DIP; DIP-33171N; -.
DR   IntAct; Q16658; 55.
DR   MINT; Q16658; -.
DR   STRING; 9606.ENSP00000371798; -.
DR   BindingDB; Q16658; -.
DR   ChEMBL; CHEMBL4523304; -.
DR   GlyGen; Q16658; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q16658; -.
DR   MetOSite; Q16658; -.
DR   PhosphoSitePlus; Q16658; -.
DR   SwissPalm; Q16658; -.
DR   BioMuta; FSCN1; -.
DR   DMDM; 2498357; -.
DR   REPRODUCTION-2DPAGE; IPI00163187; -.
DR   REPRODUCTION-2DPAGE; Q16658; -.
DR   UCD-2DPAGE; Q16658; -.
DR   CPTAC; CPTAC-1403; -.
DR   CPTAC; CPTAC-1404; -.
DR   CPTAC; CPTAC-1405; -.
DR   CPTAC; CPTAC-1406; -.
DR   CPTAC; CPTAC-373; -.
DR   CPTAC; CPTAC-709; -.
DR   EPD; Q16658; -.
DR   jPOST; Q16658; -.
DR   MassIVE; Q16658; -.
DR   MaxQB; Q16658; -.
DR   PaxDb; Q16658; -.
DR   PeptideAtlas; Q16658; -.
DR   ProteomicsDB; 61017; -.
DR   ABCD; Q16658; 1 sequenced antibody.
DR   Antibodypedia; 1483; 971 antibodies from 45 providers.
DR   CPTC; Q16658; 4 antibodies.
DR   DNASU; 6624; -.
DR   Ensembl; ENST00000382361.8; ENSP00000371798.3; ENSG00000075618.18.
DR   GeneID; 6624; -.
DR   KEGG; hsa:6624; -.
DR   MANE-Select; ENST00000382361.8; ENSP00000371798.3; NM_003088.4; NP_003079.1.
DR   UCSC; uc003sou.4; human.
DR   AGR; HGNC:11148; -.
DR   CTD; 6624; -.
DR   DisGeNET; 6624; -.
DR   GeneCards; FSCN1; -.
DR   HGNC; HGNC:11148; FSCN1.
DR   HPA; ENSG00000075618; Low tissue specificity.
DR   MIM; 602689; gene.
DR   neXtProt; NX_Q16658; -.
DR   OpenTargets; ENSG00000075618; -.
DR   PharmGKB; PA128394534; -.
DR   VEuPathDB; HostDB:ENSG00000075618; -.
DR   eggNOG; ENOG502QPRX; Eukaryota.
DR   GeneTree; ENSGT00950000183157; -.
DR   HOGENOM; CLU_030960_2_0_1; -.
DR   InParanoid; Q16658; -.
DR   OMA; YNKLAIR; -.
DR   OrthoDB; 5484756at2759; -.
DR   PhylomeDB; Q16658; -.
DR   TreeFam; TF323992; -.
DR   PathwayCommons; Q16658; -.
DR   Reactome; R-HSA-6785807; Interleukin-4 and Interleukin-13 signaling.
DR   SignaLink; Q16658; -.
DR   SIGNOR; Q16658; -.
DR   BioGRID-ORCS; 6624; 8 hits in 1158 CRISPR screens.
DR   ChiTaRS; FSCN1; human.
DR   EvolutionaryTrace; Q16658; -.
DR   GeneWiki; FSCN1; -.
DR   GenomeRNAi; 6624; -.
DR   Pharos; Q16658; Tchem.
DR   PRO; PR:Q16658; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q16658; protein.
DR   Bgee; ENSG00000075618; Expressed in stromal cell of endometrium and 185 other tissues.
DR   ExpressionAtlas; Q16658; baseline and differential.
DR   Genevisible; Q16658; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005938; C:cell cortex; IEA:UniProtKB-SubCell.
DR   GO; GO:0031253; C:cell projection membrane; IDA:UniProtKB.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0030175; C:filopodium; IDA:UniProtKB.
DR   GO; GO:0030426; C:growth cone; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0044393; C:microspike; IDA:UniProtKB.
DR   GO; GO:0005902; C:microvillus; IDA:UniProtKB.
DR   GO; GO:0002102; C:podosome; IDA:UniProtKB.
DR   GO; GO:0001726; C:ruffle; IDA:UniProtKB.
DR   GO; GO:0001725; C:stress fiber; IDA:UniProtKB.
DR   GO; GO:0003779; F:actin binding; IDA:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; IEA:InterPro.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0051017; P:actin filament bundle assembly; IDA:UniProtKB.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:0048870; P:cell motility; IDA:UniProtKB.
DR   GO; GO:0007043; P:cell-cell junction assembly; IDA:UniProtKB.
DR   GO; GO:0035089; P:establishment of apical/basal cell polarity; IDA:UniProtKB.
DR   GO; GO:0007163; P:establishment or maintenance of cell polarity; IBA:GO_Central.
DR   GO; GO:0030035; P:microspike assembly; IDA:UniProtKB.
DR   GO; GO:0030046; P:parallel actin filament bundle assembly; IDA:UniProtKB.
DR   GO; GO:0090091; P:positive regulation of extracellular matrix disassembly; IDA:UniProtKB.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; IDA:UniProtKB.
DR   GO; GO:0010592; P:positive regulation of lamellipodium assembly; IDA:UniProtKB.
DR   GO; GO:0071803; P:positive regulation of podosome assembly; IDA:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; IDA:UniProtKB.
DR   GO; GO:0032534; P:regulation of microvillus assembly; IDA:UniProtKB.
DR   CDD; cd00257; Fascin; 4.
DR   Gene3D; 2.80.10.50; -; 4.
DR   InterPro; IPR008999; Actin-crosslinking.
DR   InterPro; IPR010431; Fascin.
DR   InterPro; IPR022768; Fascin-domain.
DR   InterPro; IPR024703; Fascin_metazoans.
DR   PANTHER; PTHR10551; FASCIN; 1.
DR   PANTHER; PTHR10551:SF23; FASCIN; 1.
DR   Pfam; PF06268; Fascin; 4.
DR   PIRSF; PIRSF005682; Fascin; 1.
DR   SUPFAM; SSF50405; Actin-crosslinking proteins; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Cell junction; Cell projection;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing; Isopeptide bond;
KW   Phosphoprotein; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.9, ECO:0007744|PubMed:22223895"
FT   CHAIN           2..493
FT                   /note="Fascin"
FT                   /id="PRO_0000219379"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine"
FT                   /evidence="ECO:0000269|Ref.9, ECO:0007744|PubMed:22223895"
FT   MOD_RES         38
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         39
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:8999969,
FT                   ECO:0000305|PubMed:22155786"
FT   MOD_RES         74
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61553"
FT   MOD_RES         127
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         234
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         239
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         403
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P85845"
FT   CROSSLNK        399
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25218447"
FT   MUTAGEN         22
FT                   /note="K->E: Decreased actin-binding and loss of
FT                   actin-bundling activity; when associated with E-43 and
FT                   E-398. Decreased actin-binding and loss of actin-bundling
FT                   activity; when associated with E-43; E-100 and E-109."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         29
FT                   /note="F->A: Strongly decreases actin-bundling activity."
FT                   /evidence="ECO:0000269|PubMed:23184945"
FT   MUTAGEN         36..39
FT                   /note="SASS->AAAA: Abolishes axon growth cone collapse in
FT                   response to NGF."
FT                   /evidence="ECO:0000269|PubMed:22155786"
FT   MUTAGEN         39
FT                   /note="S->A: Loss of phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:8999969"
FT   MUTAGEN         39
FT                   /note="S->D: Phosphomimetic mutant that strongly decreases
FT                   actin-bundling activity."
FT                   /evidence="ECO:0000269|PubMed:23184945"
FT   MUTAGEN         43
FT                   /note="K->E: Decreased actin-binding and loss of
FT                   actin-bundling activity; when associated with E-22 and
FT                   E-398. Decreased actin-binding and loss of actin-bundling
FT                   activity; when associated with E-22; E-100 and E-109."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         49
FT                   /note="E->A: Strongly decreases actin-bundling activity."
FT                   /evidence="ECO:0000269|PubMed:23184945"
FT   MUTAGEN         100
FT                   /note="R->E: Mildly decreased actin-binding and
FT                   actin-bundling activity; when associated with E-109 and
FT                   E-247. Decreased actin-binding and loss of actin-bundling
FT                   activity; when associated with E-22; E-43 and E-109."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         109
FT                   /note="R->E: Mildly decreased actin-binding and
FT                   actin-bundling activity; when associated with E-100 and
FT                   E-247. Decreased actin-binding and loss of actin-bundling
FT                   activity; when associated with E-22; E-43 and E-100."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         149..151
FT                   /note="RKR->AAA: Strongly decreases actin-bundling
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:23184945"
FT   MUTAGEN         150..151
FT                   /note="KR->EE: No significant effect on actin-binding and
FT                   actin-bundling activity; when associated with E-313."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         247..250
FT                   /note="KVGK->AVGA: Decreases actin-bundling activity."
FT                   /evidence="ECO:0000269|PubMed:23184945"
FT   MUTAGEN         247
FT                   /note="K->E: Mildly decreased actin-binding and
FT                   actin-bundling activity; when associated with E-100 and
FT                   E-109."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         271
FT                   /note="R->E: Decreased actin-binding and actin-bundling
FT                   activity; when associated with E-353 and E-358."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         313
FT                   /note="K->E: No significant effect on actin-binding and
FT                   actin-bundling activity; when associated with 150-E-E-151."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         341
FT                   /note="R->E: No significant effect on actin-binding and
FT                   actin-bundling activity; when associated with E-348 and
FT                   Q-464."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         348
FT                   /note="R->E: No significant effect on actin-binding and
FT                   actin-bundling activity; when associated with E-341 and
FT                   Q-464."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         353
FT                   /note="K->E: Decreased actin-binding and actin-bundling
FT                   activity; when associated with E-271 and E-358."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         358
FT                   /note="K->A: Strongly decreases actin-bundling activity."
FT                   /evidence="ECO:0000269|PubMed:23184945"
FT   MUTAGEN         358
FT                   /note="K->E: Decreased actin-binding and actin-bundling
FT                   activity; when associated with E-271 and E-353."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         392
FT                   /note="H->A: Decreased actin-bundling activity."
FT                   /evidence="ECO:0000269|PubMed:20393565"
FT   MUTAGEN         398
FT                   /note="R->E: Decreased actin-binding and loss of
FT                   actin-bundling activity; when associated with E-22 and
FT                   E-43."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         464
FT                   /note="K->Q: No significant effect on actin-binding and
FT                   actin-bundling activity; when associated with E-341 and
FT                   E-348."
FT                   /evidence="ECO:0000269|PubMed:21685497"
FT   MUTAGEN         471
FT                   /note="K->A: Decreased actin-bundling activity."
FT                   /evidence="ECO:0000269|PubMed:20393565"
FT   MUTAGEN         488
FT                   /note="A->W: Decreased actin-bundling activity."
FT                   /evidence="ECO:0000269|PubMed:20393565"
FT   CONFLICT        440
FT                   /note="A -> V (in Ref. 8; AAH06304)"
FT                   /evidence="ECO:0000305"
FT   STRAND          14..17
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          23..26
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          28..31
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          33..39
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   HELIX           42..44
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          46..49
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   HELIX           53..55
FT                   /evidence="ECO:0007829|PDB:3P53"
FT   STRAND          60..64
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          65..67
FT                   /evidence="ECO:0007829|PDB:6B0T"
FT   STRAND          69..72
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          78..84
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   HELIX           87..89
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          91..95
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          97..99
FT                   /evidence="ECO:0007829|PDB:1DFC"
FT   STRAND          101..105
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   TURN            106..108
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          120..125
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   HELIX           128..130
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          132..138
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          140..146
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   TURN            147..150
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          151..155
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          158..160
FT                   /evidence="ECO:0007829|PDB:6I13"
FT   STRAND          162..169
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   HELIX           173..175
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          177..181
FT                   /evidence="ECO:0007829|PDB:3LLP"
FT   STRAND          183..189
FT                   /evidence="ECO:0007829|PDB:3LLP"
FT   STRAND          202..205
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   HELIX           208..210
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          212..217
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          220..224
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          230..234
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   TURN            235..238
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          239..242
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   HELIX           250..252
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          254..258
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          261..266
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   TURN            268..270
FT                   /evidence="ECO:0007829|PDB:6I10"
FT   STRAND          272..275
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          278..280
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          282..286
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   HELIX           290..292
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          294..298
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   TURN            300..302
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          305..308
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   TURN            310..312
FT                   /evidence="ECO:0007829|PDB:1DFC"
FT   STRAND          314..317
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          321..329
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   HELIX           332..334
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          336..341
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          344..348
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          354..357
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          361..369
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   HELIX           372..374
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          376..380
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          384..386
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          393..397
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   TURN            399..401
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          403..410
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          414..419
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          422..426
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          432..435
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          439..447
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          451..457
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          460..465
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          468..472
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          476..484
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   HELIX           487..489
FT                   /evidence="ECO:0007829|PDB:6I18"
FT   STRAND          490..492
FT                   /evidence="ECO:0007829|PDB:4GOV"
SQ   SEQUENCE   493 AA;  54530 MW;  C1453714BED6109A CRC64;
     MTANGTAEAV QIQFGLINCG NKYLTAEAFG FKVNASASSL KKKQIWTLEQ PPDEAGSAAV
     CLRSHLGRYL AADKDGNVTC EREVPGPDCR FLIVAHDDGR WSLQSEAHRR YFGGTEDRLS
     CFAQTVSPAE KWSVHIAMHP QVNIYSVTRK RYAHLSARPA DEIAVDRDVP WGVDSLITLA
     FQDQRYSVQT ADHRFLRHDG RLVARPEPAT GYTLEFRSGK VAFRDCEGRY LAPSGPSGTL
     KAGKATKVGK DELFALEQSC AQVVLQAANE RNVSTRQGMD LSANQDEETD QETFQLEIDR
     DTKKCAFRTH TGKYWTLTAT GGVQSTASSK NASCYFDIEW RDRRITLRAS NGKFVTSKKN
     GQLAASVETA GDSELFLMKL INRPIIVFRG EHGFIGCRKV TGTLDANRSS YDVFQLEFND
     GAYNIKDSTG KYWTVGSDSA VTSSGDTPVD FFFEFCDYNK VAIKVGGRYL KGDHAGVLKA
     SAETVDPASL WEY
//
